日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Corrigendum to 'Immunogenicity and safety of Biological E's CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study' [IJID Regions, volume 17 (2025) 100786]

对“Biological E 的 CORBEVAX™ 疫苗作为异源加强剂量在先前接种过两剂 COVISHIELD™ 或 COVAXIN 的成年志愿者中的免疫原性和安全性：一项前瞻性双盲随机 III 期临床研究”的更正 [IJID Regions，第 17 卷（2025 年）100786]

期刊:IJID Regions
影响因子:1.7
doi:10.1016/j.ijregi.2025.100831
Thuluva, Subhash; Paradkar, Vikram; Gunneri, SubbaReddy; Yerroju, Vijay; Mogulla, Rammohan Reddy; Thammireddy, Kamal; Ningaiah, Siddalingaiah; Dhar, Chirag; Binayke, Akshay; Zaheer, Aymaan; Awasthi, Amit; Narang, Shiva; Reddy, Naveen Chander; Pandey, Anil Kumar; Anjaneylu, Chitta Sitaram
免疫/内分泌
发表日期：2026
文献求助 收藏

Cytokine profiling identifies circulating IL-2, IL23 and sPD-L1 as prognostic biomarkers for treatment outcomes in non-small cell lung cancer patients undergoing anti-PD1 therapy.

细胞因子谱分析可确定循环中的 IL-2、IL23 和 sPD-L1 是接受抗 PD-1 治疗的非小细胞肺癌患者治疗结果的预后生物标志物

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1628379
Jain Kriti, Goel Anika, Mehra Deepa, Rathore Deepak Kumar, Binayke Akshay, Aggarwal Shyam, Ganguly Surajit, Awasthi Amit, Madan Evanka, Ganguly Nirmal Kumar
细胞生物学
肺癌
发表日期：2025
文献求助 收藏

Immunogenicity and safety of Biological E's CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A prospective double-blind randomized phase III clinical study

Biological E 公司的 CORBEVAX™ 疫苗作为异源加强剂在先前接种过两剂 COVISHIELD™ 或 COVAXIN 疫苗的成年志愿者中的免疫原性和安全性：一项前瞻性双盲随机 III 期临床研究

期刊:IJID Regions
影响因子:1.7
doi:10.1016/j.ijregi.2025.100786
Thuluva, Subhash; Paradkar, Vikram; Gunneri, SubbaReddy; Yerroju, Vijay; Mogulla, Rammohan Reddy; Thammireddy, Kamal; Ningaiah, Siddalingaiah; Dhar, Chirag; Binayke, Akshay; Zaheer, Aymaan; Awasthi, Amit; Narang, Shiva; Reddy, Naveen Chander; Pandey, Anil Kumar; Anjaneylu, Chitta Sitaram
免疫/内分泌
发表日期：2025
文献求助 收藏

Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial

在一项3期单盲、多中心、随机临床试验中，对Biological E公司的CORBEVAX™疫苗与COVISHIELD™（ChAdOx1 nCoV-19）疫苗的免疫原性和安全性进行了比较研究。

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2023.2203632
Thuluva, Subhash; Paradkar, Vikram; Gunneri, SubbaReddy; Yerroju, Vijay; Mogulla, Rammohan; Suneetha, Pothakamuri Venkata; Turaga, Kishore; Kyasani, Mahesh; Manoharan, Senthil Kumar; Adabala, Srikanth; Sri Javvadi, Aditya; Medigeshi, Guruprasad; Singh, Janmejay; Shaman, Heena; Binayke, Akshay; Zaheer, Aymaan; Awasthi, Amit; Singh, Chandramani; Rao A, Venkateshwar; Basu, Indranil; Kumar, Khobragade Akash Ashok; Pandey, Anil Kumar
免疫/内分泌
发表日期：2023
文献求助 收藏

Cell-Mediated Immunity (CMI) for SARS-CoV-2 Infection Among the General Population of North India: A Cross-Sectional Analysis From a Sub-sample of a Large Sero-Epidemiological Study

北印度普通人群中针对SARS-CoV-2感染的细胞介导免疫（CMI）：一项大型血清流行病学研究子样本的横断面分析

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.48824
Misra, Puneet; Garg, Pramod K; Awasthi, Amit; Kant, Shashi; Rai, Sanjay K; Ahmad, Mohammad; Guleria, Randeep; Deori, Trideep J; Mandal, Suprakash; Jaiswal, Abhishek; Gongal, Gaurav; Vishwakarma, Siddhesh; Bairwa, Mohan; Kumar, Rakesh; Haldar, Partha; Binayke, Akshay
炎症/感染
细胞生物学
SARS-CoV-2
免疫/内分泌
发表日期：2023
文献求助 收藏

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines

SARS-CoV-2 δ变异株：对疫苗有效性的持续威胁

期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(21)00697-6
Thiruvengadam, Ramachandran; Binayke, Akshay; Awasthi, Amit
SARS-CoV-2
发表日期：2022
文献求助 收藏